Is Now An Opportune Moment To Examine Svas Biosana S.p.A. (BIT:SVS)?
Oct 31
Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Healthcare Sector Analysis
UpdatedNov 02, 2025
DataAggregated Company Financials
Companies18
- 7D-1.6%
- 3M-0.3%
- 1Y-14.5%
- YTD-12.7%
Over the last 7 days, the Healthcare industry has dropped 1.6%, driven by Amplifon declining 5.4%. The industry has fallen 14% in the last year. Earnings are forecast to grow by 12% annually.
Sector Valuation and Performance
Has the Italian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 02 Nov 2025 | €22.2b | €8.8b | €886.0m | 21.6x | 25.1x | 2.5x |
| Tue, 30 Sep 2025 | €21.9b | €8.7b | €895.4m | 21x | 24.5x | 2.5x |
| Thu, 28 Aug 2025 | €23.2b | €8.7b | €902.9m | 19.8x | 25.7x | 2.7x |
| Sat, 26 Jul 2025 | €24.6b | €8.6b | €941.3m | 20.8x | 26.2x | 2.9x |
| Mon, 23 Jun 2025 | €23.9b | €25.2b | €985.5m | 20x | 24.3x | 1x |
| Wed, 21 May 2025 | €22.9b | €25.2b | €985.5m | 16.5x | 23.2x | 0.9x |
| Fri, 18 Apr 2025 | €21.4b | €20.1b | €908.1m | 18.3x | 23.6x | 1.1x |
| Sun, 16 Mar 2025 | €22.9b | €19.6b | €796.0m | 21.2x | 28.8x | 1.2x |
| Tue, 11 Feb 2025 | €25.8b | €20.0b | €828.0m | 24x | 31.2x | 1.3x |
| Thu, 09 Jan 2025 | €25.0b | €8.0b | €834.7m | 22.8x | 30x | 3.1x |
| Sat, 07 Dec 2024 | €24.6b | €19.0b | €1.4b | 19.2x | 17.2x | 1.3x |
| Mon, 04 Nov 2024 | €24.8b | €18.9b | €1.4b | 16.4x | 18.1x | 1.3x |
| Wed, 02 Oct 2024 | €25.0b | €18.9b | €1.4b | 17.1x | 18.2x | 1.3x |
| Fri, 30 Aug 2024 | €26.1b | €18.9b | €1.4b | 15.1x | 18.9x | 1.4x |
| Sun, 28 Jul 2024 | €26.0b | €18.8b | €1.4b | 17.1x | 18.8x | 1.4x |
| Tue, 25 Jun 2024 | €26.2b | €18.8b | €1.4b | 16.6x | 19x | 1.4x |
| Thu, 23 May 2024 | €26.1b | €18.8b | €1.4b | 17.4x | 18.9x | 1.4x |
| Sat, 20 Apr 2024 | €25.2b | €18.7b | €1.4b | 19.5x | 18.3x | 1.3x |
| Mon, 18 Mar 2024 | €28.3b | €18.6b | €1.4b | 20.8x | 20.3x | 1.5x |
| Wed, 14 Feb 2024 | €24.6b | €18.6b | €1.4b | 18.6x | 17.7x | 1.3x |
| Fri, 12 Jan 2024 | €24.8b | €18.6b | €1.4b | 18.2x | 17.9x | 1.3x |
| Sun, 10 Dec 2023 | €23.5b | €18.6b | €1.4b | 18.3x | 16.9x | 1.3x |
| Tue, 07 Nov 2023 | €22.6b | €18.6b | €1.4b | 16.9x | 16.1x | 1.2x |
| Thu, 05 Oct 2023 | €22.4b | €17.3b | €1.1b | 14.6x | 19.6x | 1.3x |
| Sat, 02 Sep 2023 | €23.8b | €17.3b | €1.1b | 16x | 20.9x | 1.4x |
| Mon, 31 Jul 2023 | €24.6b | €7.7b | €861.1m | 15.3x | 28.6x | 3.2x |
| Wed, 28 Jun 2023 | €23.8b | €7.7b | €822.5m | 17.7x | 29x | 3.1x |
| Fri, 26 May 2023 | €24.1b | €7.7b | €822.5m | 22.9x | 29.3x | 3.1x |
| Sun, 23 Apr 2023 | €24.1b | €7.6b | €826.9m | 21.2x | 29.1x | 3.2x |
| Tue, 21 Mar 2023 | €22.7b | €7.6b | €868.1m | 19x | 26.2x | 3x |
| Thu, 16 Feb 2023 | €23.9b | €7.4b | €886.1m | 24.6x | 27x | 3.2x |
| Sat, 14 Jan 2023 | €24.0b | €7.4b | €886.1m | 23.9x | 27.1x | 3.2x |
| Mon, 12 Dec 2022 | €24.4b | €7.4b | €886.1m | 22.3x | 27.5x | 3.3x |
| Wed, 09 Nov 2022 | €23.0b | €7.3b | €895.7m | 21.3x | 25.7x | 3.2x |
Price to Earnings Ratio
25.7x
Current Industry PE
- Investors are relatively neutral on the Italian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 23.0x.
- The 3-year average PS ratio of 2.0x is lower than the industry's current PS ratio of 2.5x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 6.2% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Italian Healthcare sector?
| IT Market | 1.39% | |
| Healthcare | -1.62% | |
| Biotech | 3.84% | |
| Pharma | -0.48% | |
| Life Sciences | -0.64% | |
| Healthtech | -2.07% | |
| Medical Equipment | -2.26% | |
| Healthcare Services | -5.02% | |
Industry PE
- Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 55.5x.
- Analysts are expecting annual earnings growth of 24.9%, which is lower than the prior year's growth of 116.9% per year.
- Investors are most pessimistic about the Life Sciences industry, which is trading below its 3-year average of 30.3x.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 25% over the next 5 years.
- However this is lower than its past earnings growth rate of 117% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 75% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PHIL Philogen | €24.80 | 4.2% +€40.3m | 26.9% | PE21.7x | |
| SVS Svas Biosana | €9.80 | 8.9% +€4.3m | 34.2% | PE7.7x |
